Vimal V.
About Vimal V.
Vimal V. is a seasoned professional with extensive experience in clinical quality assurance and regulatory affairs, currently serving as a Director at Arcellx, Inc. and holding board positions at Innovspace, GradValley Data Science, and zita.ai.
Work at Arcellx
Vimal V. serves as Director at Arcellx, Inc., a position he has held since 2021. In this role, he contributes to the strategic direction and oversight of clinical quality initiatives. His extensive background in clinical trials and quality assurance supports the company's objectives in advancing innovative therapies.
Current Roles and Board Memberships
Vimal V. holds several board positions, including Member of the Board of Directors at Innovspace - Coworking|Accelerator since 2017 and at GradValley Data Science since 2018. Additionally, he has been serving as Vice Chairperson of the Institutional Ethics Committee at Sri Ramakrishna Hospital since 2018. He also joined zita.ai as a Member of the Board of Directors in 2021.
Previous Experience in Clinical Quality
Vimal V. has held significant roles in clinical quality across various organizations. He was Director of Clinical Quality at MyoKardia from 2019 to 2020 and at Bristol Myers Squibb from 2020 to 2021. His previous experience also includes a long tenure at Genentech as Strategy Lead for Clinical Quality Assurance & Risk Management from 2008 to 2015.
Education and Expertise
Vimal V. earned a PhD in Biochemistry from the University of Madras, studying from 1999 to 2001. He also completed Project Management studies in Medical Clinical Sciences at Northwestern University in 2008. He is certified as a Regulatory Affairs Professional (RAC) with a focus on USFDA and global strategy, and he has expertise in clinical trials, regenerative medicine, and translational research.
Leadership and Team Management
Vimal V. has demonstrated significant leadership capabilities throughout his career. He has led teams of up to 40 members, showcasing his ability to manage and guide professionals in high-stakes environments. His leadership experience spans various roles in clinical quality and research, emphasizing his strategic approach to team management.